Résultats de la recherche - 1 result
A dose-escalation study of combretastatin A4-phosphate in healthy dogs.
seem to be well tolerated. The severity of the neurotoxicity observed at 100 mg m(-2), although transient, does not invite to use this dose in canine oncology patients. Health Topics: Animal health ...